EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

COVID-19 with high-sensitivity CRP associated with worse dynamic clinical parameters and outcomes

Kunapa Iam-Arunthai, Supat Chamnanchanunt, Pravinwan Thungthong, Anongnart Chinapha, Chajchawan Nakhahes, Tawatchai Suwanban, Tsukuru Umemura

Frontiers in Medicine · 22.04.2024 · 11

DOI: 10.3389/fmed.2024.1346646 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Medicine, online erschienen am 22.04.2024. Verfasst von Kunapa Iam-Arunthai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Department of Medicine, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to evaluate the relationship between high-sensitivity C-reactive protein (hsCRP) in hospitalized COVID-19 patients and their clinical outcomes, including trajectory of hsCRP changes during hospitalization. Method and results Patients with positive COVID-19 tests between 2021 and 2023 were admitted to two hospitals. Among 184 adult patients, approximately half (47.3%) had elevated hsCRP levels upon admission, which defined as exceeding the laboratory-specific upper limit of test (> 5.0 mg/L). Clinical outcomes included critical illness, acute kidney injury, thrombotic events, intensive care unit (ICU) requirement, and death during hospitalization. Elevated hsCRP levels had a higher risk of ICU requirement than those with normal, 39.1% versus 16.5%; adjusted odds ratio (aOR), 2.3 [95% CI, 1.05–5.01]; p = 0.036. Patients with extremely high (≥2 times) hsCRP levels had aOR, 2.65 [95% CI, 1.09–6.45]; p < 0.001. On the fifth day hospitalization, patients with high hsCRP levels associated with acute kidney injury (aOR, 4.13 [95% CI, 1.30–13.08]; p = 0.016), ICU requirement (aOR, 2.67 [95%CI, 1.02–6.99]; p = 0.044), or death (aOR, 4.24 [95% CI, 1.38-12.99]; p = 0.011). The likelihood of worse clinical outcomes increased as hsCRP levels rose; patients with elevated hsCRP had lower overall survival rate than those with normal ( p = 0.02). The subset of high hsCRP patients with high viral load also had a shorter half-life compared to those with normal hsCRP level ( p = 0.003).

Conclusion

Elevated hsCRP levels were found to be a significant predictor of ICU requirement, acute kidney injury, or death within 5 days after hospitalization in COVID-19 patients. This emphasized the importance of providing more intensive care management to patients with elevated hsCRP.

Schlagwörter

Stichwörter der Autor:innen

COVID-19Hs-CRPclinical outcomecritical illnessmortality

Autor:innen und Institutionen

  • Division of Hematology, Department of Medicine, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand.
  • Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
  • Division of Infectious Diseases, Department of Medicine, Rajavithi Hospital, College of Medicine, Rangsit University, Bangkok, Thailand.
  • Department of Medical Technology and Sciences, International University of Health and Welfare, Okawa, Japan.

Zitieren

APA

Iam-Arunthai, K., Chamnanchanunt, S., Thungthong, P., Chinapha, A., Nakhahes, C., Suwanban, T., & Umemura, T. (2024). COVID-19 with high-sensitivity CRP associated with worse dynamic clinical parameters and outcomes. Frontiers in Medicine, 11. https://doi.org/10.3389/fmed.2024.1346646

Vancouver

Iam-Arunthai K, Chamnanchanunt S, Thungthong P, Chinapha A, Nakhahes C, Suwanban T, et al. COVID-19 with high-sensitivity CRP associated with worse dynamic clinical parameters and outcomes. Frontiers in Medicine. 2024;11. doi:10.3389/fmed.2024.1346646

BibTeX
@article{IamArunthai2024,
  author = {Iam-Arunthai, Kunapa and Chamnanchanunt, Supat and Thungthong, Pravinwan and Chinapha, Anongnart and Nakhahes, Chajchawan and Suwanban, Tawatchai and Umemura, Tsukuru},
  title = {COVID-19 with high-sensitivity CRP associated with worse dynamic clinical parameters and outcomes},
  journal = {Frontiers in Medicine},
  year = {2024},
  volume = {11},
  doi = {10.3389/fmed.2024.1346646}
}
Kostenlos starten →